U.S. Food and Drug Administration
Silver Spring, Maryland
Christina Capacci-Daniel is a Quality Assessment Lead and reviewer in the FDA Office of Pharmaceutical Quality, Office of Process and Facilities. She has a PhD in Organic Chemistry from Georgetown University where she studied crystallization process design and polymorphic control. As part of the early technical research and development group at Novartis Pharmaceuticals, she developed analytical methods, designed drug products for clinical trials, and worked on innovative drug delivery and manufacturing technology. Since joining the FDA in 2013, she has reviewed the manufacturing process and facilities for new and generic drug applications and performed pre-approval inspections. In addition to participating in the FDA Emerging Technology Program, she was a part of the FDA Guidance for Industry "Quality Considerations for Continuous Manufacturing" working group.
Wednesday, November 6
1:30 PM – 2:30 PM